Pharmaconutrition Review: Physiological Mechanisms

Journal of Parenteral and Enteral Nutrition

Volumn 37, Issue , 2013, Pages 51S-65S

  Pierre, Joseph F ^b   Heneghan, Aaron F ^b   Lawson, Christy M ^c   Wischmeyer, Paul E ^d   Kozar, Rosemary A ^e   Kudsk, Kenneth A ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

immune modulation; immunonutrition; nutrition therapy; pharmaconutrition

Indexed keywords

EID: 84898379040     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607113493326     Document Type: Article

References (223)

1. Villet S, Chiolero RL, Bollmann MD, et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005; 24(4):502-509.
2. Rubinson L, Diette GB, Song X, Brower RG, Krishnan JA. Low caloric intake is associated with nosocomial bloodstream infections in patients in the medical intensive care unit. Crit Care Med. 2004; 32(2):350-357.
3. Barr J, Hecht M, Flavin KE, Khorana A, Gould MK. Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest. 2004; 125(4):1446-1457.
4. Artinian V, Krayem H, DiGiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest. 2006; 129(4):960-967.
5. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol. 2008; 24(2):215-222.
6. Brosnan JT. Interorgan amino acid transport and its regulation. J Nutr. 2003; 133(6)(suppl 1):2068S-2072S.
7. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990; 48(8):297-309.
8. ParryBillings M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppression after major burns? Lancet. 1990; 336(8714):523-525.
9. Planas M, Schwartz S, Arbós MA, Farriol M. Plasma glutamine levels in septic patients. JPEN J Parenter Enteral Nutr. 1993; 17(3):299-300.
10. Hasselgren PO, Pedersen P, Sax HC, Warner BW, Fischer JE. Current concepts of protein turnover and amino acid transport in liver and skeletal muscle during sepsis. Arch Surg. 1988; 123(8):992-999.
11. Gamrin L, Essén P, Forsberg AM, Hultman E, Wernerman J. A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med. 1996; 24(4):575-583.
12. Wernerman J, Hammarqvist F, Gamrin L, Essén P. Protein metabolism in critical illness. Baillieres Clin Endocrinol Metab. 1996; 10(4):603-615.
13. Newsholme EA, Crabtree B, Ardawi MS. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol. 1985; 70(4):473-489.
14. Wilmore DW. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr. 2001; 131(9)(suppl):2543S-2549S; discussion 2550S-2551S.
15. Hankard RG, Haymond MW, Darmaun D. Role of glutamine as a glucose precursor in fasting humans. Diabetes. 1997; 46(10):1535-1541.
16. Hanna M, Kudsk K. Nutritional and pharmacological enhancement of gut-associated lymphoid tissue. Can J Gastroenterol. 2000; 14(suppl D):145D-151D.
17. Li J, Kudsk K, Janu P, Renegar K. Effect of glutamine-enriched total parenteral nutrition on small intestinal gut-associated lymphoid tissue and upper respiratory tract immunity. Surgery. 1997; 121(5):542-549.
18. Kudsk K, Wu Y, Fukatsu K, et al. Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels. JPEN J Parenter Enteral Nutr. 2000; 24(5):270-275.
19. Li J, King B, Janu P, Renegar K, Kudsk K. Glycyl-L-glutamine–enriched total parenteral nutrition maintains small intestine gut-associated lymphoid tissue and upper respiratory tract immunity. JPEN J Parenter Enteral Nutr. 2000; 22(1):31-36.
20. Newsholme EA, Crabtree B, Ardawi MS. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep. 1985; 5(5):393-400.
21. Cory JG, Cory AH. Critical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: asparaginase treatment in childhood acute lymphoblastic leukemia. In Vivo. 2006; 20(5):587-589.
22. Roth E, Spittler A, Oehler R. Glutamine: effects on the immune system, protein balance and intestinal functions [in German]. Wien Klin Wochenschr. 1996; 108(21):669-676.
23. dos Santos RG, Viana ML, Generoso SV, Arantes RE, Davisson Correia MI, Cardoso VN. Glutamine supplementation decreases intestinal permeability and preserves gut mucosa integrity in an experimental mouse model. JPEN J Parenter Enteral Nutr. 2010; 34(4):408-413.
24. McQuiggan M, Kozar R, Sailors RM, Ahn C, McKinley B, Moore F. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPEN J Parenter Enteral Nutr. 2008; 32(1): 28-35.
25. Wang L, Maher TJ, Wurtman RJ. Oral L-glutamine increases GABA levels in striatal tissue and extracellular fluid. FASEB J. 2007; 21(4): 1227-1232.
26. Curi R, Lagranha CJ, Doi SQ, et al. Molecular mechanisms of glutamine action. J Cell Physiol. 2005; 204(2):392-401.
27. Wischmeyer PE, Musch MW, Madonna MB, Thisted R, Chang EB. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol. 1997; 272(4, pt 1):G879-G884.
28. Wischmeyer PE. Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol. 2008; 24(2):190-197.
29. Yang R, Tan X, Thomas AM, et al. Alanine-glutamine dipeptide (AGD) inhibits expression of inflammation-related genes in hemorrhagic shock. JPEN J Parenter Enteral Nutr. 2007; 31(1):32-36.
30. Luo M, Fernandez-Estivariz C, Jones DP, et al. Depletion of plasma antioxidants in surgical intensive care unit patients requiring parenteral feeding: effects of parenteral nutrition with or without alanyl-glutamine dipeptide supplementation. Nutrition. 2008; 24(1):37-44.
31. Mizock BA. Immunonutrition and critical illness: an update. Nutrition. 2010; 26(7-8):701-707.
32. Luo M, Bazargan N, Griffith DP, et al. Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study. Clin Nutr. 2008; 27(2): 297-306.
33. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol. 2001; 90(6):2403-2410.
34. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock. 2001; 16(5):398-402.
35. Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med. 2005; 33(6):1206-1213.
36. Wischmeyer PE, Riehm J, Singleton KD, et al. Glutamine attenuates tumor necrosis factor–alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition. 2003; 19(1):1-6.
37. Singleton KD, Beckey VE, Wischmeyer PE. Glutamine prevents activation of NKkappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock. 2005; 24(6):583-589.
38. Singleton KD, Wischmeyer PE. Glutamine’s protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol. 2007; 292(5):R1839-R1845.
39. Ziegler TR, Ogden LG, Singleton KD, et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med. 2005; 31(8):1079-1086.
40. Yan H, Zhang Y, Lv SJ, et al. Effects of glutamine treatment on myocardial damage and cardiac function in rats after severe burn injury. Int J Clin Exp Pathol. 2012; 5(7):651-659.
41. Critical Care Nutrition. Canadian clinical practice guidelines. http://www.criticalcarenutrition.com. Accessed September 15, 2012.
42. Goeters C, Wenn A, Mertes N, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002; 30(9):2032-2037.
43. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition. 1997; 13(4):295-302.
44. Ziegler TR, May A, Hebber G, Kudsk KA, Sax H, Blumberg H, Easley K, Wischmeyer P. Glutamine dipeptide–supplemented parenteral nutrition in surgical ICU patients: results of an American randomized double-blind, multicenter trial [abstract]. The European Society of Parenteral and Enteral Nutrition. 2012. https://b-com.mci-group.com/Abstract/Statistics/AbstractStatisticsViewPage.aspx?AbstractID=127390
45. Garrel D, Patenaude J, Nedelec B, et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med. 2003; 31(10):2444-2449.
46. Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003; 27(4):241-245.
47. Martindale RG, McClave SA, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med. 2009; 37(5):1757-1761.
48. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P; Canadian Critical Care Clinical Practice Guidelines Committee. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003; 27(5):355-373.
49. Stechmiller JK, Childress B, Cowan L. Arginine supplementation and wound healing. Nutr Clin Pract. 2005; 20(1):52-61.
50. Morris SM. Recent advances in arginine metabolism. Curr Opin Clin Nutr Metab Care. 2004; 7(1):45-51.
51. Albina JE, Mills CD, Henry WL, Caldwell MD. Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway. J Immunol. 1989; 143(11):3641-3646.
52. Gianotti L, Alexander JW, Pyles T, Fukushima R. Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance: the role of nitric oxide. Ann Surg. 1993; 217(6): 644-654.
53. Marin VB, Rodriguez-Osiac L, Schlessinger L, Villegas J, Lopez M, Castillo-Duran C. Controlled study of enteral arginine supplementation in burned children: impact on immunologic and metabolic status. Nutrition. 2006; 22(7-8):705-712.
54. Tong BC, Barbul A. Cellular and physiological effects of arginine. Mini Rev Med Chem. 2004; 4(8):823-832.
55. Clemmensen C, Madsen AN, Smajilovic S, Holst B, Bräuner-Osborne H. L-arginine improves multiple physiological parameters in mice exposed to diet-induced metabolic disturbances. Amino Acids. 2012; 43(3): 1265-1275.
56. Krause MS, McClenaghan NH, Flatt PR, de Bittencourt PI, Murphy C, Newsholme P. L-arginine is essential for pancreatic β-cell functional integrity, metabolism and defense from inflammatory challenge. J Endocrinol. 2011; 211(1):87-97.
57. Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood. 2007; 109(4):1568-1573.
58. Rodriguez PC, Zea AH, DeSalvo J, et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol. 2003; 171(3):1232-1239.
59. Kemen M, Senkal M, Homann HH, et al. Early postoperative enteral nutrition with arginine–omega-3 fatty acids and ribonucleic acid–supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med. 1995; 23(4):652-659.
60. Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem. 2002; 277(24):21123-21129.
61. Kubis N, Richer C, Domergue V, Giudicelli JF, Lévy BI. Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt–/–). J Hypertens. 2002; 20(8):1581-1587.
62. DeLano FA, Parks DA, Ruedi JM, Babior BM, Schmid-Schönbein GW. Microvascular display of xanthine oxidase and NADPH oxidase in the spontaneously hypertensive rat. Microcirculation. 2006; 13(7):551-566.
63. Gross A, Spiesser S, Terraza A, Rouot B, Caron E, Dornand J. Expression and bactericidal activity of nitric oxide synthase in Brucella suis–infected murine macrophages. Infect Immun. 1998; 66(4):1309-1316.
64. Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care. 2003; 6(2):223-228.
65. Hibbs JB. Infection and nitric oxide. J Infect Dis. 2002; 185(suppl 1): S9-S17.
66. Fink MP. Modulating the L-arginine–nitric oxide pathway in septic shock: choosing the proper point of attack. Crit Care Med. 1999; 27(9): 2019-2022.
67. deRojas-Walker T, Tamir S, Ji H, Wishnok JS, Tannenbaum SR. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem Res Toxicol. 1995; 8(3):473-477.
68. O’Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res. 2001; 88(1):12-21.
69. Ochoa JB, Bernard AC, O’Brien WE, et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg. 2001; 233(3): 393-399.
70. Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998; 336(pt 1):1-17.
71. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci. 1999; 55(8-9):1015-1028.
72. Bistrian BR. Practical recommendations for immune-enhancing diets. J Nutr. 2004; 134(10)(suppl):2868S-2872S; discussion 2895S.
73. Kalil AC, Sevransky JE, Myers DE, et al. Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock. Crit Care Med. 2006; 34(11):2719-2728.
74. Gonce SJ, Peck MD, Alexander JW, Miskell PW. Arginine supplementation and its effect on established peritonitis in guinea pigs. JPEN J Parenter Enteral Nutr. 1990; 14(3):237-244.
75. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991; 214(5):621-626.
76. Caparrós T, Lopez J, Grau T. Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet: the effect on nosocomial infections and outcome. JPEN J Parenter Enteral Nutr. 2001; 25(6): 299-309.
77. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999; 27(12): 2799-2805.
78. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001; 286(8):944-953.
79. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg. 1999; 229(4):467-477.
80. Montejo JC, Zarazaga A, López-Martínez J, et al. Immunonutrition in the intensive care unit: a systematic review and consensus statement. Clin Nutr. 2003; 22(3):221-233.
81. Waitzberg DL, Saito H, Plank LD, et al. Postsurgical infections are reduced with specialized nutrition support. World J Surg. 2006; 30(8):1592-1604.
82. Zaloga GP, Roberts PR, Marik P. Feeding the hemodynamically unstable patient: a critical evaluation of the evidence. Nutr Clin Pract. 2003; 18(4):285-293.
83. Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr. 2006; 136(1)(suppl):227S-231S.
84. Woods SC, Seeley RJ, Cota D. Regulation of food intake through hypothalamic signaling networks involving mTOR. Annu Rev Nutr. 2008; 28: 295-311.
85. Lang CH, Deshpande N, Frost RA. Leucine acutely reverses burn-induced alterations in translation initiation in heart. Shock. 2004; 22(4):326-332.
86. Kudsk K. Catabolic states and immune dysfunction: relation to gastrointestinal feeding. Nestle Nutr Workshop Ser Clin Perform Programme. 2000; 3: 157-172.
87. Kudsk K, Chioléro R. Current concepts in nutrition. Curr Opin Clin Nutr Metab Care. 2005; 8(2):167-170.
88. Kudsk K. Immunonutrition in surgery and critical care. Annu Rev Nutr. 2006; 26: 463-479.
89. Manelli JC, Garabedian M, Ounis N, Houvenaeghel M, Ottomani A, Bimar J. Effects on muscular and general proteolysis in burn patients of a solution enriched with branched amino acids [in French]. Ann Fr Anesth Reanim. 1984; 3(4):256-260.
90. King P, Power DM. Branched chain amino/keto acid supplementation following severe burn injury: a preliminary report. Clin Nutr. 1990; 9(4): 226-230.
91. Schmitz JE, Dölp R, Grünert A, Ahnefeld FW. The effect of solutions of varying branched-chain concentration on the plasma amino acid pattern and metabolism in intensive care patients. Clin Nutr. 1982; 1(2):147-158.
92. Vente JP, Soeters PB, von Meyenfeldt MF, Rouflart MM, van der Linden CJ, Gouma DJ. Prospective randomized double-blind trial of branched chain amino acid enriched versus standard parenteral nutrition solutions in traumatized and septic patients. World J Surg. 1991; 15(1):128-133.
93. Pelosi G, Proietti R, Magalini SI, Santori R, Giammaria A, Manni C. Anticatabolic properties of branched chain amino acids in trauma. Resuscitation. 1983; 10(3):153-158.
94. Cerra FB, Upson D, Angelico R, et al. Branched chains support postoperative protein synthesis. Surgery. 1982; 92(2):192-199.
95. Cynober LA. Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002; 18(9):761-766.
96. De Bandt JP, Cynober L. Therapeutic use of branched-chain amino acids in burn, trauma, and sepsis. J Nutr. 2006; 136(1)(suppl):308S-313S.
97. Deckelbaum RJ, Torrejon C. The omega-3 fatty acid nutritional landscape: health benefits and sources. J Nutr. 2012; 142(3):587S-591S.
98. Todd SR, Gonzalez EA, Turner K, Kozar RA. Update on postinjury nutrition. Curr Opin Crit Care. 2008; 14(6):690-695.
99. Bosma KJ, Taneja R, Lewis JF. Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches. Drugs. 2010; 70(10):1255-1282.
100. Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013; 75(3): 645-662.
101. Calder PC. Rationale and use of n-3 fatty acids in artificial nutrition. Proc Nutr Soc. 2010; 69(4):565-573.
102. Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol. 2009; 158(4):960-971.
103. Ootsuka Y, Blessing WW, Steiner AA, Romanovsky AA. Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling. Am J Physiol Regul Integr Comp Physiol. 2008; 294(4):R1294-R1303.
104. Aldridge C, Razzak A, Babcock TA, Helton WS, Espat NJ. Lipopolysaccharide-stimulated RAW 264.7 macrophage inducible nitric oxide synthase and nitric oxide production is decreased by an omega-3 fatty acid lipid emulsion. J Surg Res. 2008; 149(2):296-302.
105. Carpentier YA, Hacquebard M, Portois L, Dupont IE, Deckelbaum RJ, Malaisse WJ. Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium-chain triacylglycerol:fish-oil emulsion in humans. Am J Clin Nutr. 2010; 91(4):875-882.
106. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002; 56(8):365-379.
107. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma- linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006; 34(4):1033-1038.
108. Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006; 34(9):2325-2333.
109. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999; 27(8):1409-1420.
110. Pontes-Arruda A, Martins LF, de Lima SM, et al. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit Care. 2011; 15(3):R144.
111. Theilla M, Singer P, Cohen J, Dekeyser F. A diet enriched in eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clin Nutr. 2007; 26(6): 752-757.
112. Rice TW, Wheeler AP, Thompson BT, et al. Enteral omega-3 fatty acid, γ-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011; 306(14):1574-1581.
113. Xu QL, Cai C, Qi WW, Xia ZG, Tang YZ. Influence of omega-3 polyunsaturated fatty acids on inflammation-related parameters in lung tissue of rats with severe scald [in Chinese]. Zhonghua Shao Shang Za Zhi. 2011; 27(5):358-362.
114. Hsu CC, Wang JJ. L-ascorbic acid and alpha-tocopherol attenuates liver ischemia-reperfusion induced of cardiac function impairment. Transplant Proc. 2012; 44(4):933-936.
115. Wang NT, Lin HI, Yeh DY, et al. Effects of the antioxidants lycium barbarum and ascorbic acid on reperfusion liver injury in rats. Transplant Proc. 2009; 41(10):4110-4113.
116. Erkut B, Özyazıcıoğlu A, Karapolat BS, et al. Effects of ascorbic acid, alpha-tocopherol and allopurinol on ischemia-reperfusion injury in rabbit skeletal muscle: an experimental study. Drug Target Insights. 2007; 2: 249-258.
117. Dwenger A, Pape HC, Bantel C, et al. Ascorbic acid reduces the endotoxin- induced lung injury in awake sheep. Eur J Clin Invest. 1994; 24(4): 229-235.
118. Fisher BJ, Kraskauskas D, Martin EJ, et al. Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. Am J Physiol Lung Cell Mol Physiol. 2012; 303(1):L20-L32.
119. Wilson JX, Wu F. Vitamin C in sepsis. Subcell Biochem. 2012; 56: 67-83.
120. Bowie AG, O’Neill LA. Vitamin C inhibits NF–kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol. 2000; 165(12):7180-7188.
121. Bucca C, Rolla G, Oliva A, Farina JC. Effect of vitamin C on histamine bronchial responsiveness of patients with allergic rhinitis. Ann Allergy. 1990; 65(4):311-314.
122. Zhou G, Kamenos G, Pendem S, Wilson JX, Wu F. Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis. Am J Physiol Regul Integr Comp Physiol. 2012; 302(4): R409-R416.
123. Kahn SA, Beers RJ, Lentz CW. Resuscitation after severe burn injury using high-dose ascorbic acid: a retrospective review. J Burn Care Res. 2011; 32(1):110-117.
124. Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch Surg. 2000; 135(3):326-331.
125. Sriram K, Lonchyna VA. Micronutrient supplementation in adult nutrition therapy: practical considerations. JPEN J Parenter Enteral Nutr. 2009; 33(5):548-562.
126. Lu J, Holmgren A. Selenoproteins. J Biol Chem. 2009; 284(2):723-727.
127. Squires JE, Berry MJ. Eukaryotic selenoprotein synthesis: mechanistic insight incorporating new factors and new functions for old factors. IUBMB Life. 2008; 60(4):232-235.
128. Sunde RA. Molecular biology of selenoproteins. Annu Rev Nutr. 1990; 10: 451-474.
129. Vincent JL, Forceville X. Critically elucidating the role of selenium. Curr Opin Anaesthesiol. 2008; 21(2):148-154.
130. Sunde RA, Hoekstra WG. Incorporation of selenium from selenite and selenocystine into glutathione peroxidase in the isolated perfused rat liver. Biochem Biophys Res Commun. 1980; 93(4):1181-1188.
131. Sunde RA. Molecular biomarker panels for assessment of selenium status in rats. Exp Biol Med (Maywood). 2010; 235(9):1046-1052.
132. Arthur JR, McKenzie RC, Beckett GJ. Selenium in the immune system. J Nutr. 2003; 133(5)(suppl 1):1457S-1459S.
133. Forman HJ, Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 2002; 166(12, pt 2):S4-S8.
134. Arther JR, McKenzie RC, Backett GJ. Selenium in the immune system. J Nutr. 2003; 133(5):14575-14595.
135. Hill KE, Burk RF. Selenoprotein P: recent studies in rats and in humans. Biomed Environ Sci. 1997; 10(2-3):198-208.
136. Westphal K, Stangl V, Fähling M, et al. Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells. Free Radic Biol Med. 2009; 47(11):1652-1660.
137. Valenta J, Brodska H, Drabek T, Hendl J, Kazda A. High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med. 2011; 37(5):808-815.
138. Sattar N, Scott HR, McMillan DC, Talwar D, O’Reilly DS, Fell GS. Acute-phase reactants and plasma trace element concentrations in non–small cell lung cancer patients and controls. Nutr Cancer. 1997; 28(3): 308-312.
139. Lowes DA, Galley HF. Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis. Biochem J. 2011; 436(1):123-132.
140. Berger MM, Reymond MJ, Shenkin A, et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med. 2001; 27(1):91-100.
141. Cheung MC, Zhao XQ, Chait A, Albers JJ, Brown BG. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol. 2001; 21(8):1320-1326.
142. Peretz AM, Nève JD, Famaey JP. Selenium in rheumatic diseases. Semin Arthritis Rheum. 1991; 20(5):305-316.
143. Berger MM, Shenkin A, Revelly JP, et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in crtically ill patients. Am J Clin Nutr. 2004; 80(2):410-416.
144. Forceville X. Selenium and the “free” electron. Selenium—a trace to be followed in septic or inflammatory ICU patients? Intensive Care Med. 2001; 27(1):16-18.
145. Angstwurm MW, Engelmann L, Zimmermann T, et al. Selenium in intensive care (SIC): results of a prospective randomized, placebo- controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007; 35(1):118-126.
146. Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004; 28(6):S39-S70.
147. Tipton IH, Cook MJ. Trace elements in human tissue, II: adult subjects from the United States. Health Phys. 1963; 9: 103-145.
148. Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. 2008; 43(5):370-377.
149. Cander B, Dundar ZD, Gul M, Girisgin S. Prognostic value of serum zinc levels in critically ill patients. J Crit Care. 2011; 26(1):42-46.
150. Golden MH, Harland PS, Golden BE, Jackson AA. Zinc and immunocompetence in protein-energy malnutrition. Lancet. 1978; 1(8076):1226-1228.
151. Golden MH, Golden BE, Jackson AA. Skin breakdown in kwashiorkor responds to zinc. Lancet. 1980; 1(8180):1256.
152. Fernandes G, Nair M, Onoe K, Tanaka T, Floyd R, Good RA. Impairment of cell-mediated immunity functions by dietary zinc deficiency in mice. Proc Natl Acad Sci U S A. 1979; 76(1):457-461.
153. Prasad AS. Trace elements: biochemical and clinical effects of zinc and copper. Am J Hematol. 1979; 6(1):77-87.
154. Prasad AS, Meftah S, Abdallah J, et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988; 82(4):1202-1210.
155. Besecker BY, Exline MC, Hollyfield J, et al. A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. Am J Clin Nutr. 2011; 93(6):1356-1364.
156. Wessels I, Haase H, Engelhardt G, Rink L, Uciechowski P. Zinc deficiency induces production of the proinflammatory cytokines IL-1β and TNFα in promyeloid cells via epigenetic and redox-dependent mechanisms. J Nutr Biochem. 2013; 24(1):289-297.
157. Weeks CS, Tanabe H, Cummings JE, et al. Matrix metalloproteinase-7 activation of mouse paneth cell pro-alpha-defensins: SER43 down arrow ILE44 proteolysis enables membrane-disruptive activity. J Biol Chem. 2006; 281(39):28932-28942.
158. Zhong Y, Cai D, Cai W, Geng S, Chen L, Han T. Protective effect of galactooligosaccharide-supplemented enteral nutrition on intestinal barrier function in rats with severe acute pancreatitis. Clin Nutr. 2009; 28(5): 575-580.
159. Zhong W, McClain CJ, Cave M, Kang YJ, Zhou Z. The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol. 2010; 298(5):G625-G633.
160. Lowe NM, Fekete K, Decsi T. Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr. 2009; 89(6):2040S-2051S.
161. Patrick J, Dervish C. Leukocyte zinc in the assessment of zinc status. Crit Rev Clin Lab Sci. 1984; 20(2):95-114.
162. Heyland DK, Jones N, Cvijanovich NZ, Wong H. Zinc supplementation in critically ill patients: a key pharmaconutrient? JPEN J Parenter Enteral Nutr. 2008; 32(5):509-519.
163. Wolman SL, Anderson GH, Marliss EB, Jeejeebhoy KN. Zinc in total parenteral nutrition: requirements and metabolic effects. Gastroenterology. 1979; 76(3):458-467.
164. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth. 1999; 83(2):302-320.
165. Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol. 1994; 102(5):616-622.
166. Chernow B, Bamberger S, Stoiko M, et al. Hypomagnesemia in patients in postoperative intensive care. Chest. 1989; 95(2):391-397.
167. Bobkowski W, Nowak A, Durlach J. The importance of magnesium status in the pathophysiology of mitral valve prolapse. Magnes Res. 2005; 18(1):35-52.
168. Pachikian BD, Neyrinck AM, Deldicque L, et al. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J Nutr. 2010; 140(3):509-514.
169. Fuller R. Probiotics in human medicine. Gut. 1991; 32(4):439-442.
170. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008; 111: 1-66.
171. Morrow LE, Gogineni V, Malesker MA. Probiotic, prebiotic, and synbiotic use in critically ill patients. Curr Opin Crit Care. 2012; 18(2): 186-191.
172. Morrow LE, Gogineni V, Malesker MA. Probiotics in the intensive care unit. Nutr Clin Pract. 2012; 27(2):235-241.
173. Gerritsen J, Timmerman HM, Fuentes S, et al. Correlation between protection against sepsis by probiotic therapy and stimulation of a novel bacterial phylotype. Appl Environ Microbiol. 2011; 77(21):7749-7756.
174. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011; 6(3):209-240.
175. Shu Q, Qu F, Gill HS. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr. 2001; 33(2):171-177.
176. Gill HS, Shu Q, Lin H, Rutherfurd KJ, Cross ML. Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med Microbiol Immunol. 2001; 190(3):97-104.
177. Kelsall BL. Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation. J Pathol. 2008; 214(2):242-259.
178. Möndel M, Schroeder BO, Zimmermann K, et al. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol. 2009; 2(2):166-172.
179. Schlee M, Harder J, Köten B, Stange EF, Wehkamp J, Fellermann K. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol. 2008; 151(3):528-535.
180. Schauber J, Svanholm C, Termén S, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut. 2003; 52(5):735-741.
181. de Vrese M, Marteau PR. Probiotics and prebiotics: effects on diarrhea. J Nutr. 2007; 137(3)(suppl 2):803S-811S.
182. Lammers KM, Helwig U, Swennen E, et al. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol. 2002; 97(5):1182-1186.
183. Otte JM, Podolsky DK. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004; 286(4):G613-G626.
184. Neish AS, Gewirtz AT, Zeng H, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 2000; 289(5484):1560-1563.
185. Sumi Y, Miyakawa M, Kanzaki M, Kotake Y. Vitamin B-6 deficiency in germfree rats. J Nutr. 1977; 107(9):1707-1714.
186. Hirayama K, Uetsuka K, Kuwabara Y, Tamura M, Itoh K. Vitamin K deficiency of germfree mice caused by feeding standard purified diet sterilized by gamma-irradiation. Exp Anim. 2007; 56(4):273-278.
187. Shirakawa H, Komai M, Kimura S. Antibiotic-induced vitamin K deficiency and the role of the presence of intestinal flora. Int J Vitam Nutr Res. 1990; 60(3):245-251.
188. Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2010; 8(3):171-184.
189. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D. Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol. 2008; 10(1-2):37-54.
190. Luongo D, D’Arienzo R, Bergamo P, Maurano F, Rossi M. Immunomodulation of gut-associated lymphoid tissue: current perspectives. Int Rev Immunol. 2009; 28(6):446-464.
191. Woodcock NP, McNaught CE, Morgan DR, Gregg KL, MacFie J. An investigation into the effect of a probiotic on gut immune function in surgical patients. Clin Nutr. 2004; 23(5):1069-1073.
192. Gil A, Rueda R. Interaction of early diet and the development of the immune system. Nutr Res Rev. 2002; 15(2):263-292.
193. Li J, Kudsk KA, Gocinski B, Dent D, Glezer J, Langkamp-Henken B. Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue. J Trauma. 1995; 39(1):44-52.
194. Sano Y, Hermsen J, Kang W, et al. Parenteral nutrition maintains pulmonary IgA antibody transport capacity, but not active transport, following injury. Am J Surg. 2009; 198(1):105-109.
195. Sano Y, Gomez F, Hermsen J, et al. Parenteral nutrition induces organ specific alterations in polymeric immunoglobulin receptor levels. J Surg Res. 2008; 149(2):236-242.
196. Fukatsu K, Kudsk K, Zarzaur B, Wu Y, Hanna M, DeWitt R. TPN decreases IL-4 and IL-10 mRNA expression in lipopolysaccharide stimulated intestinal lamina propria cells but glutamine supplementation preserves the expression. Shock. 2001; 15(4):318-322.
197. Alverdy J, Stern E. Effect of immunonutrition on virulence strategies in bacteria. Nutrition. 1998; 14(7-8):580-584.
198. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol. 1994; 10(1):55-63.
199. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992; 32(2):141-144.
200. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun. 1996; 64(12):5403-5405.
201. Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organisation global guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012; 46(6):468-481.
202. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010; 90(3):859-904.
203. Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu Rev Pathol. 2012; 7: 99-122.
204. Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant. 2005; 5(1):125-130.
205. Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002; 74(1):123-127.
206. Rayes N, Seehofer D, Theruvath T, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007; 246(1):36-41.
207. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg. 2006; 30(10):1848-1855.
208. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr. 2007; 31(2): 119-126.
209. Wierdsma NJ, van Bodegraven AA, Uitdehaag BM, et al. Fructo-oligosaccharides and fibre in enteral nutrition has a beneficial influence on microbiota and gastrointestinal quality of life. Scand J Gastroenterol. 2009; 44(7):804-812.
210. Kulkarni AD, Rudolph FB, Van Buren CT. The role of dietary sources of nucleotides in immune function: a review. J Nutr. 1994; 124(8)(suppl):1442S-1446S.
211. Van Buren CT, Kulkarni AD, Rudolph FB. The role of nucleotides in adult nutrition. J Nutr. 1994; 124(1)(suppl):160S-164S.
212. Suchner U, Kuhn KS, Fürst P. The scientific basis of immunonutrition. Proc Nutr Soc. 2000; 59(4):553-563.
213. Jyonouchi H, Sun S, Sato S. Nucleotide-free diet suppresses antigen-driven cytokine production by primed T cells: effects of supplemental nucleotides and dietary fatty acids. Nutrition. 1996; 12(9):608-615.
214. Jyonouchi H, Zhang-Shanbhag L, Tomita Y, Yokoyama H. Nucleotide-free diet impairs T-helper cell functions in antibody production in response to T-dependent antigens in normal C57B1/6 mice. J Nutr. 1994; 124(4):475-484.
215. Jyonouchi H, Zhang L, Gross M, Tomita Y. Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr Cancer. 1994; 21(1):47-58.
216. Uauy R, Stringel G, Thomas R, Quan R. Effect of dietary nucleosides on growth and maturation of the developing gut in the rat. J Pediatr Gastroenterol Nutr. 1990; 10(4):497-503.
217. Kulkarni A, Fanslow W, Higley H, Pizzini R, Rudolph F, Van Buren C. Expression of immune cell surface markers in vivo and immune competence in mice by dietary nucleotides. Transplant Proc. 1989; 21(1, pt 1):121-124.
218. Adjei AA, Yamauchi K, Chan YC, Konishi M, Yamamoto S. Comparative effects of dietary nucleoside-nucleotide mixture and its components on endotoxin induced bacterial translocation and small intestinal injury in protein deficient mice. Gut. 1996; 38(4):531-537.
219. Kishibuchi M, Tsujinaka T, Yano M, et al. Effects of nucleosides and a nucleotide mixture on gut mucosal barrier function on parenteral nutrition in rats. JPEN J Parenter Enteral Nutr. 1997; 21(2):104-111.
220. Kudsk KA, Tolley EA, DeWitt RC, et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr. 2003; 27(1):1-9.
221. Ohzato H, Yoshizaki K, Nishimoto N, et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery. 1992; 111(2):201-209.
222. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg. 1992; 79(8): 757-760.
223. Kudsk KA, Minard G, Wojtysiak SL, Croce M, Fabian T, Brown RO. Visceral protein response to enteral versus parenteral nutrition and sepsis in patients with trauma. Surgery. 1994; 116(3):516-523.